Assignee
OGD2 PHARMA
FR6 patents
Top patents by PatentIndex Score
US10611848B2Apr 7, 2020
Antibody against GD2-O-acetylated ganglioside with pro-apoptotic activity
OGD2 PHARMA1 citations55
US11440968B2Sep 13, 2022
Humanized antibody against O-acetylated GD2 ganglioside (OAcGD2)
OGD2 PHARMA0 citations54
US10745489B2Aug 18, 2020
Targeting o-acetylated gd2 ganglioside as a new therapeutic and diagnostic strategy for Cancer Stem Cells cancer
OGD2 PHARMA1 citations54
US10000575B2Jun 19, 2018
Targeting O-acetylated GD2 ganglioside as a new therapeutic and diagnostic strategy for cancer stem cells cancer
OGD2 PHARMA2 citations54
US11697689B2Jul 11, 2023
Use of antibody against O-acetylated GD2 ganglioside to improve the therapeutic potential of drugs
OGD2 PHARMA1 citations50
US10669328B2Jun 2, 2020
Human IgG1 derived antibody with pro-apoptotic activity
OGD2 PHARMA0 citations34